History Mission Strategic plan Role The FAMHP also ensures that … Our core business Our organisation Organisation chart Our vision and values Vision and ambition Values Commitments by federal administrations Our stakeholders Partners FAMHP customer charter Partners receiving financial support from the FAMHP The FAMHP and European projects Disclaimer Transparency Social media Conditions for reuse (Creative Commons-0 licence)
13/11/2023 PRAC November 2023 – Conclusion regarding available evidence not supporting link between the glucagon-like peptide-1 (GLP-1) receptor agonists and thyroid cancer
26/10/2023 Limited availability of GLP-1 analogues: recommendations for medical doctors (specialists), (hospital) pharmacists and patients